3.5.4.10	drug development	the enzyme is a potential target for antineoplastic intervention, design of IMPCH inhibitors, overview	687546	
3.5.4.10	drug development	the enzyme is an important drug target	756701	
3.5.4.10	medicine	determination of differentially expressed genes in HT-29 cells, both after short treatment with methotrexate and after the resistance to methotrexate has been established. Enzyme as well as survivin and inosine monophosphate dehydrogenase type II are upregulated	668561